NTS and neoplasm: Supplementing young CAR-T cells with NMN + 78c during the ex vivo expansion did not result in improved tumor growth control (Extended Data Fig. 5a) or increased persistence in vivo (Extended Data Fig. 5b), indicating that NMN + 78c treatment restores CAR-T cell functionality specifically in the context of aging.